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Classes I and II import pathwayPeroxisome is a single-membrane organelle in eukaryotes. The functional importance of peroxisomes in
humans is highlighted by peroxisome-deﬁcient peroxisome biogenesis disorders (PBDs) such as Zellweger
syndrome (ZS). Gene defects of peroxins required for both membrane assembly and matrix protein import
are identiﬁed: ten mammalian pathogenic peroxins for ten complementation groups of PBDs, are required
for matrix protein import; three, Pex3p, Pex16p and Pex19p, are shown to be essential for peroxisome mem-
brane assembly and responsible for the most severe ZS in PBDs of three complementation groups 12, 9, and
14, respectively. Patients with severe ZS with defects of PEX3, PEX16, and PEX19 tend to carry severe mutation
such as nonsense mutations, frameshifts and deletions. With respect to the function of these three peroxins
in membrane biogenesis, two distinct pathways have been proposed for the import of peroxisomal mem-
brane proteins in mammalian cells: a Pex19p- and Pex3p-dependent class I pathway and a Pex19p- and
Pex16p-dependent class II pathway. In class II pathway, Pex19p also forms a soluble complex with newly
synthesized Pex3p as the chaperone for Pex3p in the cytosol and directly translocates it to peroxisomes.
Pex16p functions as the peroxisomal membrane receptor that is speciﬁc to the Pex3p-Pex19p complexes. A
model for the import of peroxisomal membrane proteins is suggested, providing new insights into the molec-
ular mechanisms underlying the biogenesis of peroxisomes and its regulation involving Pex3p, Pex19p, and
Pex16p. Another model suggests that in Saccharomyces cerevisiae peroxisomes likely emerge from the endo-
plasmic reticulum. This article is part of a Special Issue entitled: Metabolic Functions and Biogenesis of per-
oxisomes in Health and Disease.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Peroxisome is a single-membrane-bounded ubiquitous organelle
containing about hundred enzymes that catalyze various metabolic
pathways, including β-oxidation of very long-chain fatty acids, the
synthesis of ether lipids such as plasmalogens and bile–acid metabo-
lism [1]. Peroxisome was discovered as a microbody in 1954 and
functionally named peroxisomes in 1965. In all types of cells,hinese hamster ovary; ER, en-
rder; PMP, peroxisomal mem-
lic Functions and Biogenesis of
culty of Sciences, Kyushu Uni-
u, Fukuoka 812-8581, Japan.
rights reserved.peroxisome was deﬁned to contain one or more enzymes that use
molecular oxygen to remove hydrogen atoms and form hydrogen
peroxide from organic substrates. Catalase, a typical marker enzyme
of peroxisomal matrix, degrades hydrogen peroxide.
2. Peroxisome biogenesis disorders (PBDs)
2.1. Genetic heterogeneity
Inborn errors of peroxisomes are classiﬁed into two categories:
PBDs and single-enzyme deﬁciencies [2,3]. Generalized PBDs include
cerebrohepatorenal Zellweger syndrome (ZS), the most severe phe-
notype; neonatal adrenoleukodystrophy (NALD), the intermediate;
and infantile Refsum disease (IRD), the least severe phenotype.
Rhizomelic chondrodysplasia punctata (RCDP) is a partial PBD. Ge-
netic heterogeneity is seen in subjects with PBDs [4–6]. Thirteen com-
plementation groups (CGs) have been identiﬁed, mainly by pair-wise
combination of cell-fusion analysis of the patient-derived ﬁbroblasts
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to the largest incidence CG1 (E).
Cells from patients classiﬁed in most CGs of the Zellweger spectrum
(CGs 1, 2, 3, 4, 7, 8, 10, 11, or 13) are characterized by the presence of per-
oxisomal remnant structures that contain a number of peroxisomal
membrane proteins (PMPs) but no or only residual amounts of matrix
proteins [7–9] (Table 1) . This suggests that the genes defective in these
CGs are involved in peroxisomal matrix protein import. In contrast, cells
from patients classiﬁed in CG9, CG12 or CG14 are devoid of peroxisomal
remnant structures [10–15]. This indicates that the genes defective in
these CGs are required for peroxisome membrane biogenesis.2.2. Pathogenic genes
2.2.1. Expression cloning of peroxin cDNAs
Genetic phenotype complementation of peroxisome assembly-
defectivemutants of mammalian somatic cells such as Chinese hamster
ovary (CHO) cells and of several yeast species including Saccharomyces
cerevisiae, Pichia pastoris,Hansenula polymorpha, and Yarrowia lipolytica
have led to identiﬁcation and characterization of numerous genes, ter-
med PEXs, encoding peroxins that are essential for peroxisome biogen-
esis [7,16,17]. Two mutually distinct but complementary approaches
have been taken in order to isolate mammalian PEX genes.
A direct cloning approach has been taken by means of genetic com-
plementation with peroxin cDNAs essential for assembly of peroxi-
somes in CHO cells. PEX2 (formerly PAF-1) encoding the 35-kDa
membrane peroxin Pex2p with RING zinc-ﬁnger motif was cloned for
the ﬁrst time [18]. Expression of PEX2 in ﬁbroblasts from a ZS patient
of CG10 (F) complemented the impaired peroxisome assembly [19].
Dysfunction of PEX2 caused by a homozygous nonsense point mutation
at R119ter was shown for the ﬁrst time to be responsible for ZS, a pro-
totype of the PBDs [19]. A transient expression assay has also been de-
veloped for further isolation of PEX cDNAs. A cDNA library divided
into small pools was transfected into peroxisome assembly-defective
CHO cell mutants, and positive clones were searched for by immunocy-
tochemical staining of restored peroxisomes, or more recently by using
a readily visible GFP-peroxisomal targeting signal 1 (PTS1) fusion pro-
tein. Eight other peroxin cDNAs, PEX1, PEX3, PEX5, PEX6, PEX12, PEX13,
PEX14, PEX19, and PEX26, have been cloned by the transient functional
phenotype-complementation assay on CHO cell mutants [3,7] (Fig. 2).Table 1
Complementation groups (CG) and PEX genes of peroxisome deﬁciencies.
Gene Chromosome
location
CG Phenotype
US/EU Japan
PEX1 7q21-22 1 E ZS, NALDa, IRDa
PEX2 8q21.1 10 F ZS, IRDa
PEX3 6q23-24 12 G ZS
PEX5 12p13.3 2 ZS, NALD
PEX6 6p21.1 4 (6) C ZS, NALDa
PEX7 6q21-22.2 11 R RCDP
PEX10 1p36.32 7 (5) B ZS, NALD
PEX12 17q21.1 3 ZS, NALD, IRD
PEX13 2p14-16 13 H ZS, NALDa
PEX14 1p36.22 15 K ZS
PEX16 11p11.11 9 D ZS
PEX19 1q22 14 J ZS
PEX26 22q11.21 8 A ZS, NALDa, IRDa
ZS, Zellweger syndrome; IRD, infantile Refsum disease; NALD, neonatal adrenoleukodystrop
TPR, tetratricopeptide repeat.
a Temperature-sensitive phenotype.These PEXs were shown to be the pathogenic genes responsible for
PBDs of nine CGs [5–7] (Table 1).
2.2.2. Expressed sequence tag database search
As an alternative strategy, the homology search by screening the
human expressed sequence tag database using yeast PEX genes has
successfully led to isolation of human ortholog genes responsible for
PBDs: PEX1, PEX3, PEX5, PEX6, PEX7, PEX10, PEX12, PEX13, and PEX16
[5,7]. Within a dozen years after the ﬁrst isolation of the ZS gene,
PEX2, all of pathogenic genes responsible for PBDs of currently identi-
ﬁed 13 CGs have been successfully cloned by such extensive search
and the expressed sequence tag homology method.
3. Peroxins essential for membrane assembly of peroxisomes
Of 13 peroxins required for peroxisome biogenesis, three peroxins,
Pex3p, Pex16p, and Pex19p, are identiﬁed as essential factors for PMP
assembly in several species including humans [10–15,20–23]. Pex3p
serves as the membrane-anchoring site for Pex19p; Pex16p, a peroxin
absent in most yeasts [13,24], is shown to be the receptor for Pex19p
complexes with newly synthesized Pex3p in mammalian cells [25];
Pex19p is a predominantly cytoplasmic protein that shows a broad
PMP-binding speciﬁcity (Fig. 1).
3.1. Gene defects of peroxins required for both membrane assembly and
matrix protein import
Three mammalian pathogenic peroxins, Pex3p, Pex16p,
and Pex19p, have been isolated and their mutations are shown
to be responsible for ZS of three CGs, CG12 (G), CG9 (D), and
CG14 (J), respectively [5–7].
3.1.1. Pex3p
PEX3 encodes 42-kDa integral membrane protein of peroxisomes
[14,26]. Upon expression of PEX3 in a CHO pex3 mutant [26] and ﬁ-
broblasts from three ZS patients of CG12 (G) [14], peroxisomal mem-
brane vesicles were assembled before the import of soluble proteins
such as PTS1 and PTS2 proteins [6,14,15,27–29], as in pex19 and
pex16 patients' cells (see below), implying the temporally differenti-
ated translocation of matrix proteins into peroxisomal membrane
vesicles. Two types of inactivating mutations, exon 11 deletion andCHO mutants Peroxisome
ghosts
Peroxin
(kDa) Characteristics
Z24, ZP107 + 143 AAA family
Z65 + 35 PMP, RING
ZPG208 − 42 PMP
ZP105a, ZP139 + 68 PTS1 receptor,
TPR family
ZP92 + 104 AAA family
ZPG207 + 36 PTS2 receptor,
WD motif
+ 37 PMP, RING
ZP109 + 40 PMP, RING
ZP128 + 44 PMP, PTS1-P,
SH3
ZP110 + 41 PMP, PTS-DP,
PTS2-DP
− 39 PMP
ZP119 − 33 CAAX motif
ZP124, ZP167 + 34 PMP, Pex1p-
Pex6p recruiter
hy; RCDP, rhizomelic chondrodysplasia punctata; PMP, peroxisome membrane protein;
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were identiﬁed in the ZS patients [14,27,28].
3.1.2. Pex16p
Fibroblasts from a ZS patient of CG9 (D) are defective in peroxi-
somal membrane biogenesis and morphologically devoid of peroxi-
somal remnants, as in PEX3- and PEX19-defective ﬁbroblasts of
CG12 (G) and CG14 (J), respectively. Expression of PEX16 encoding
336-amino-acid peroxisomal membrane protein restored peroxisom-
al membrane assembly and matrix protein import in CG9 (D) ﬁbro-
blasts [10,13], of which mutation was identiﬁed to be a homozygous
nonsense mutation R176ter [10]. More recently, other mutations are
identiﬁed: exon 10 skip [30] and ﬁve novel parent homozygous mu-
tations [31].
3.1.3. Pex19p
PEX19 encodes 33-kDa farnesylated protein partly anchoring to
peroxisome membranes [11]. PEX19 expression complemented im-
paired peroxisome biogenesis in ﬁbroblasts from a patient with
CG14 (J) PBD. This patient possessed a homozygous, inactivating mu-
tation: a one-base insertion, A764, in a codon for Met255, resulted in
a frameshift. Upon transfection of PEX19 into a CHO pex19 mutant
ZP119 devoid of peroxisomal ghosts, the most striking was formation
of peroxisomal membranes, followed by import of matrix proteins
[11,12]. This was the ﬁrst observation of the membrane assembly pro-
cess during peroxisome biogenesis, particularly differentiated from
the import of soluble proteins.Fig. 1. A schematic view of peroxisome biogenesis inmammals. The subcellular localization an
(1) peroxins that are required for matrix protein import; (2) those including Pex3p, Pex16p an
three forms of Pex11p, Pex11pα, Pex11pβ, and Pex11pγ, apparently involved in peroxisome pr
and Pex7p, respectively, in the cytoplasm. Two isoforms, Pex5pS and Pex5pL, of Pex5p are identi
and Pex5pL to peroxisomes, where Pex14p functions as a convergent, initial docking site of the
Pex7p, carrying its cargo PTS2 protein in the cytosol and translocates the Pex7p–PTS2 protein
inside of peroxisomes, downstream of Pex14p and upstream of Pex13p. Pex5p and Pex7p s
comprising the RING peroxins, Pex2p, Pex10p, and Pex12p. Both Pex5p and Pex7p ﬁnally shu
initially targets to an800-kDa docking complex containingPex14p and then translocates to a 50
import reaction, Pex1p and Pex6p of the AAA family catalyze the export of Pex5p, where Cys-uCollectively, Pex3p, Pex16p and Pex19p are categorized as a
peroxin essential for the assembly of peroxisome membranes. They
function as essential factors required for the translocation process of
membrane proteins and membrane vesicle assembly in a concerted
manner. Two distinct pathways have recently been suggested for
the import of PMPs: a Pex19p- and Pex3p-dependent class I pathway
for PMP-import complex, except for Pex3p [32,33] and a Pex19p- and
Pex16p-dependent class II pathway for Pex3p [25] (Fig. 2). It is note-
worthy that C-tailed anchor type peroxins including yeast Pex15p
and mammalian Pex26p, the recruiter of Pex1p-Pex6p complex, are
transported in a Pex19p-dependent [34], class I pathway (Yagita
and Fujiki, unpublished data).3.2. Involvement of endoplasmic reticulum (ER) in peroxisome assembly
In regard to the origin of peroxisomal membrane, in early 60s
ER was proposed to be involved in peroxisome biogenesis, based
on the observation of the close proximity in electron micrographs
of these two functionally and morphologically distinct organelles
[35]. Two decades later, however, the post-translational import of
peroxisomal matrix proteins was reported, hence implying a view
that peroxisome is an autonomous organelle [36]. Recently, several
groups suggested a different view of peroxisomal membrane bio-
genesis that peroxisomes are formed from ER upon induction of
Pex3p [37–39], although the signiﬁcance of such observations re-
mains under debate. More recently, a study [40] suggests that per-
oxisomes are generally formed by growth and division underd molecular characteristics of peroxins are shown. Peroxins are divided into three groups:
d Pex19p, responsible for peroxisome membrane assembly (see Fig. 2); (3) those such as
oliferation together with DLP1 and Fis1. PTS1- and PTS2-proteins are recognized by Pex5p
ﬁed inmammals. PTS1 proteins are transported by homo- andhetero-oligomers of Pex5pS
‘protein import machinery’ translocon. Pex5pL directly interacts with the PTS2 receptor,
complex to Pex14p. PTS1 and PTS2 proteins are then released at the inner surface and/or
ubsequently translocate to other translocon components, termed translocation complex
ttle back to the cytosol. In regard to peroxisome-cytoplasmic shuttling of Pex5p, Pex5p
0-kDa translocation complex comprising RINGperoxins. At the terminal step of the protein
biquitination of Pex5p is prerequisite to the Pex5p exit.
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isome is present in a cell, they can be formed from the ER after ex-
pression of the complementing PEX gene, whilst another study
[41–43] proposes that all peroxisomal membrane proteins are
transported via ER. Meanwhile, we demonstrated that Pex3p, the
membrane receptor for Pex19p-complexes with PMPs including
Pex16p, is directly targeted to peroxisomes in a Pex19p–Pex16p
dependent class II pathway in mammalian cells such as CHO and
human cell lines [25]. Moreover, it is noteworthy that several per-
oxisomal membrane proteins might be translocated to peroxisomes
via ER [44–46], likely implying a sort of semi-autonomous property
of peroxisomes. At any event, the issue with respect to how perox-
isome membrane is assembled is one of the important and of high
interest problems to be tackled.
4. Genotype–phenotype relationships
Patients with milder form of PBDs, NALD and IRD, tend to have less
severe biochemical abnormalities, whose specimen such as skin ﬁbro-
blasts likely contain residual peroxisomes, occasionally termed mosai-
cism. However, clinical severity or prognosis of a patient with PBDs
cannot be easily predicted solely on the basis of biochemical analyses.
Various types of mutations such as nonsense point mutations, missense
mutations, insertion and deletion of nucleotides mostly with concomi-
tant frameshift, splicing defect, etc. in both homozygotic and
heterozygotic alleles have been identiﬁed in PBD patients [5,6,47].Fig. 2. A model for early stages of peroxisomal membrane biogenesis involving mutu-
ally dependent targeting of Pex3p and Pex16p, termed as classes I and II pathways. The
initial membranes harboring Pex3p or Pex16p culminate in indistinguishable, matured
peroxisomes. Pex19p forms complexes with newly synthesized PMPs including Pex16p
in the cytosol and transports them to the membrane protein receptor Pex3p, whereby
peroxisome membrane is assembled (class I pathway). With respect to biogenesis of
Pex3p, Pex19p likewise forms a complex with newly synthesized Pex3p and translo-
cates it to the Pex3p receptor, Pex16p (class II pathway). Of note, peroxisomes are as-
sembled no matter which pathway initially proceeds.Patients with severe ZS tend to carry severe mutation such as nonsense
mutations, frameshifts, and deletions, whilst many of NALD or IRD pa-
tients frequently possessmissensemutations [5,6,47]. There is also a re-
lationship between severe phenotype and absence of ghosts. Defects of
PEX3, PEX16, and PEX19 encodingmembrane-assembly peroxins lead to
the absence of ghosts and cause ZS phenotypes. Many cell lines from
milder PBD patients with missense PEX mutations showed a ts pheno-
type, restoration of peroxisome biogenesis at 30 °C [48–51].
4.1. Animal models for PBDs
Search for pathogenic genes responsible for all CGs of PBDs is accom-
plished. Prenatal DNA diagnosis using PEX genes is now possible for
PBDs of all 13 CGs.
Currently ongoing and future investigations using the cloned peroxins
and pexmutants including ﬁbroblasts from patients with PBDs, CHO cell
mutants, and PEX gene knockout mice such as PEX2 [52], PEX5 [53,54],
PEX11 [55], and PEX13 [56] shed light on themechanisms underlying per-
oxisome biogenesis and pathogenesis of PBDs. However, gene-knockout
mice for PEX3, PEX16, and PEX19 have not been established yet.
It is noteworthy that invertebrate models including Caenorhabditis
elegans [57,58] and Drospohila melanogaster [59,60] for PBDs have
recently been established.
5. Concluding remarks
Three mammalian pathogenic peroxins, Pex3p, Pex16p, and Pex19p,
have been isolated. Genetic defects of PEX3, PEX16, and PEX19 encoding
these membrane-assembly peroxins lead to the absence of ghosts and
cause ZS phenotypes of three CGs, CG12 (G), CG9 (D), and CG14 (J),
respectively. In contrast to themolecular mechanisms underlying import
of peroxisomal matrix proteins, those involving the transport of mem-
brane proteins remain less understood. Two distinct pathways have
recently been proposed for the import of PMPs: a Pex19p- and Pex3p-
dependent class I pathway and a Pex19p-dependent and Pex16p-
dependent class II pathway. A model for the import of PMPs is suggested
(Fig. 2), providing new insights into the molecular mechanisms underly-
ing the biogenesis of peroxisomes and its regulation involving Pex3p,
Pex19p, and Pex16p. Peroxisomes are recently suggested to be generally
formed by growth and division under normal conditions and that only
under a condition where no peroxisome is present in a cell, they can be
formed from the ER after expression of the complementing PEX gene,
whilst another study proposes that all peroxisomal membrane proteins
are transported via ER. Future studies would shed light on these tackling
issues.
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